Remove 2008 Remove Pharmaceutical Companies Remove Process Improvement
article thumbnail

An Evaluation of Postapproval CMC Change Timelines

ISPE

In addition to delaying optimization of manufacturing and controls, these types of long delays for approvals discourage continuous process improvements for approved products. Consequently, comparing results across companies and through time will establish an increasingly robust perspective of trends in global approval durations.